Mercaptopurine (6-MP) Starting Dose Guidance TPMT / NUDT15 phenotype Recommended starting dose Normal metabolizer (NM/NM) 100% standard dose Single intermediate metabolizer (TPMT or NUDT15 IM) 3080% of standard dose Compound IM (TPMT IM + NUDT15 IM) 2050% of standard dose Any poor metabolizer (TPMT PM and/or NUDT15 PM) ~10% of dose + reduced frequency (e.g., 3/week) Non-malignant disease + PM Avoid thiopurines Azathioprine Non-Malignant Conditions TPMT / NUDT15 phenotype Recommended starting dose Normal metabolizer 100% standard dose (e.g
It acts as a mitochondrial messenger that communicates with the nucleus to maintain cellular homeostasis, making it a promising target for research on metabolic health, exercise performance, and healthy aging 1-4
A Cost Comparison: Program Models To make this more concrete, let's break down the different ways you can access these treatments and what they generally entail
The risks depend, among other factors, on which product was used, where it was injected, how deeply it was injected, whether sterile technique was used and whether there are underlying medical conditions or medications
Consider rapid sequence induction of anesthesia for intubation if retained gastric contents are present, using shared decision-making to weigh procedure cancellation vs
Reprinted with exclusive permission.